SOLAND DANIEL B
SEC insider (Form 3/4/5 filer). CIK 0001318485. Director at ACADIA PHARMACEUTICALS INC (ACAD). 3 reported Form 4/5 transactions since Sep 2024; latest on May 29, 2025. Located in SAN DIEGO, CA.
Companies SOLAND DANIEL B has filed insider reports for
- ACADIA PHARMACEUTICALS INC (ACAD): Director
SOLAND DANIEL B
CIK: 0001318485
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (33.3%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ACAD
ACADIA PHARMACEUTICALS INC
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- May 29, 2025ACAD
ACADIA PHARMACEUTICALS INC
ExerciseDirect9.4K shares- - May 29, 2025ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectDirector Stock Options (Right to Buy)
13.8K shares- - May 29, 2025ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectRestricted Stock Units
8.1K shares-
1-3 of 3 transactions